Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway

References

• Kamihara J, Bourdeaut F, Foulkes WD, Molenaar JJ, Mosse YP, Nakagawara A, Parareda A, Scollon SR, Schneider KW, Skalet AH, et al. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017;23(13):e98–e106. doi:10.1158/1078-0432.CCR-17-0652.
   PubMed Web of Science ®Google Scholar
• Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021. doi:10.1038/nrdp.2015.21.
   PubMed Web of Science ®Google Scholar
• Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. Retinoblastoma in Asia. Eye (Lond). 2019;33(1):87–96. doi:10.1038/s41433-018-0244-7.
   PubMed Web of Science ®Google Scholar
• Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84(12):937–44. doi:10.1007/s12098-017-2395-0.
   PubMed Web of Science ®Google Scholar
• Kaewkhaw R, Rojanaporn D. Retinoblastoma: etiology, modeling, and treatment. Cancers (Basel). 2020;12(8):2304. doi:10.3390/cancers12082304.
   Web of Science ®Google Scholar
• Ren S, Lin P, Wang J, Yu H, Lv T, Sun L, Circular DG. RNAs: promising molecular biomarkers of human aging-related diseases via functioning as an miRNA sponge. Mol Ther Methods Clin Dev. 2020;18:215–29. doi:10.1016/j.omtm.2020.05.027.
   PubMed Web of Science ®Google Scholar
• Wu J, Qi X, Liu L, Hu X, Liu J, Yang J, Yang J, Lu L, Zhang Z, Ma S, et al. Emerging epigenetic regulation of circular RNAs in human cancer. Mol Ther Nucleic Acids. 2019;16:589–96. doi:10.1016/j.omtn.2019.04.011.
   PubMedGoogle Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. Onco Targets Ther. 2020;13:2067–92. doi:10.2147/OTT.S233672.
   PubMed Web of Science ®Google Scholar
• Yin L, Chen J, Ma C, Pei S, Du M, Zhang Y, Feng Y, Yin R, Bian X, He X, et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell Death Dis. 2020;11(7):562. doi:10.1038/s41419-020-02785-3.
   PubMed Web of Science ®Google Scholar
• Wang X, Tao G, Huang D, Liang S, Zheng D. Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA4855p/CKS1B axis. Oncol Rep. 2020;44(5):2009–20. doi:10.3892/or.2020.7758.
   PubMed Web of Science ®Google Scholar
• Ding J, Wang Q, Guo N, Wang H, Chen H, Ni G, Li P. CircRNA circ_0072995 promotes the progression of epithelial ovarian cancer by modulating miR-147a/CDK6 axis. Aging (Albany NY). 2020;12(17):17209–23. doi:10.18632/aging.103668.
   PubMedGoogle Scholar
• Chen NN, Chao DL, Li XG. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochem Funct. 2020;38(8):1036–46. doi:10.1002/cbf.3535.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Croce CM. microRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol. 2011;51:25–43. doi:10.1146/annurev-pharmtox-010510-100517.
   PubMed Web of Science ®Google Scholar
• Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 2019;58:90–99. doi:10.1016/j.semcancer.2018.12.002.
   PubMed Web of Science ®Google Scholar
• Golabchi K, Soleimani-Jelodar R, Aghadoost N, Momeni F, Moridikia A, Nahand JS, Masoudifar A, Razmjoo H, Mirzaei H. MicroRNAs in retinoblastoma: potential diagnostic and therapeutic biomarkers. J Cell Physiol. 2018;233(4):3016–23. doi:10.1002/jcp.26070.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang Q, Liang Y. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway. J Cell Biochem. 2020;121(3):2294–302. doi:10.1002/jcb.29453.
   PubMed Web of Science ®Google Scholar
• Xu L, Li W, Shi Q, Wang M, Li H, Yang X, Zhang J. MicroRNA936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway. Oncol Rep. 2020;43(2):635–45. doi:10.3892/or.2020.7456.
   PubMed Web of Science ®Google Scholar
• Li W, Wang J, Zhang D, Zhang X, Xu J, Zhao L. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/beta-catenin pathway. Cancer Biomark. 2019;25(1):79–88. doi:10.3233/CBM-182315.
   PubMed Web of Science ®Google Scholar
• Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19(1):30. doi:10.1186/s12943-020-1135-7.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–91. doi:10.1038/s41576-019-0158-7.
   PubMed Web of Science ®Google Scholar
• Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–90. doi:10.1038/s41580-020-0243-y.
   PubMed Web of Science ®Google Scholar
• Guo N, Liu XF, Pant OP, Zhou DD, Hao JL, Lu CW. Circular RNAs: novel promising biomarkers in ocular diseases. Int J Med Sci. 2019;16(4):513–18. doi:10.7150/ijms.29750.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F, Ren D, Ye X, Li C, Wang Y, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79. doi:10.1186/s12943-018-0827-8.
   PubMed Web of Science ®Google Scholar
• Cui X, Wang J, Guo Z, Li M, Li M, Liu S, Liu H, Li W, Yin X, Tao J, et al. Emerging function and potential diagnostic value of circular RNAs in cancer. Mol Cancer. 2018;17(1):123. doi:10.1186/s12943-018-0877-y.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Xiao F, Wang L, Wang T, Chen L. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Mol Cell Biochem. 2020. doi:10.1007/s11010-020-03886-5.
   Web of Science ®Google Scholar
• Wang H, Li M, Cui H, Song X, Sha Q. CircDHDDS/miR-361-3p/WNT3A axis promotes the development of retinoblastoma by regulating proliferation, cell cycle, migration, and invasion of retinoblastoma cells. Neurochem Res. 2020;45(11):2691–702. doi:10.1007/s11064-020-03112-0.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu J, Li Y, Jiang Y, Wang L, Chen Y, Lv Y, Zou Y, Ding X. Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis. Cancer Cell Int. 2020;20:301. doi:10.1186/s12935-020-01396-4.
   PubMed Web of Science ®Google Scholar
• Niu X, Yang B, Liu F, Fang Q. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. Biomed Pharmacother. 2020;121:109623. doi:10.1016/j.biopha.2019.109623.
   PubMed Web of Science ®Google Scholar
• Luo H, Yang L, Liu C, Wang X, Dong Q, Liu L, Wei Q. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer. Int J Biochem Cell Biol. 2020;122:105702. doi:10.1016/j.biocel.2020.105702.
   PubMed Web of Science ®Google Scholar
• Liao S, Xing S, Ma Y. LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma. Cancer Chemother Pharmacol. 2019;83(6):1065–74. doi:10.1007/s00280-019-03822-5.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79. doi:10.1146/annurev-biochem-060308-103103.
   PubMed Web of Science ®Google Scholar
• Shi XY, Wang H, Wang W, Gu YH. MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2. Eur Rev Med Pharmacol Sci. 2019;23(7):2847–55. doi:10.26355/eurrev_201904_17562.
   PubMed Web of Science ®Google Scholar
• Ke SB, Qiu H, Chen JM, Shi W, Han C, Gong Y, Chen YS. ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p. Pathol Res Pract. 2020;216(3):152761. doi:10.1016/j.prp.2019.152761.
   PubMed Web of Science ®Google Scholar
• Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417. doi:10.1038/s41571-020-0341-y.
   PubMed Web of Science ®Google Scholar
• Schimmer AD, Dalili S, Batey RA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 2006;13(2):179–88. doi:10.1038/sj.cdd.4401826.
   PubMed Web of Science ®Google Scholar
• Abbas R, Larisch S. Targeting XIAP for promoting cancer cell death-the story of ARTS and SMAC. Cells. 2020;9(3):663. doi:10.3390/cells9030663.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang L, Lu L, Wang Y. miR-214-3p regulates multi-drug resistance and apoptosis in retinoblastoma cells by targeting ABCB1 and XIAP. Onco Targets Ther. 2020;13:803–11. doi:10.2147/OTT.S235862.
   PubMed Web of Science ®Google Scholar